EVIDENCE LIBRARY
What Does a Null Alcohol–Alprazolam Interaction Mean for an Impairment Opinion?
A crossover trial found cognitive impairment after 1 mg alprazolam, alone or with alcohol, but no clear additive effect at the achieved alcohol exposure. Timing and reporting limits prevent a conclusion of safety.
A failure to detect an additive alcohol effect does not mean that alcohol plus alprazolam left performance intact. In a 20-person crossover trial, alprazolam alone and combined with alcohol impaired several cognitive outcomes relative to placebo. The combination did not clearly worsen performance beyond alprazolam alone under the tested exposure and timing.
A four-condition comparison
Aitken and colleagues tested healthy adults on separate, randomized, double-blind sessions with placebo, alcohol, 1 mg alprazolam, and their combination. The analyzed sample comprised 12 women and eight men, with a mean age of 28.6 years. Cognitive testing began approximately 30 and 100 minutes after dosing.
Alcohol exposure was measured with a breath instrument and converted to a BAC estimate using a fixed 2300:1 ratio. Peak mean estimates were 0.030% with alcohol alone and 0.031% with the combination, below the stated 0.04% target. They were not direct laboratory whole-blood ethanol measurements.
Alprazolam, by contrast, was quantified in venous whole blood. A drug concentration and a breath-derived ethanol estimate should retain those different measurement identities.
Performance was impaired despite the null interaction
At 100 minutes, simple reaction time was slower after alprazolam alone and after the combination than after placebo. Mean times were approximately 316 and 320 milliseconds, respectively, versus 295 milliseconds on placebo. Both placebo comparisons were statistically significant.
Other affected outcomes included choice reaction time, digit vigilance and working-memory measures. Delayed word recall at 100 minutes was significantly poorer with alprazolam alone and with the combination than with placebo. However, not every endpoint showed the same pattern or significant pairwise comparisons.
Alcohol alone did not significantly impair the selected cognitive outcomes at the achieved exposure. It did increase self-reported sedation. A subjective effect and a measurable deficit on a short cognitive task are separate outcomes.
The peak effects did not coincide
Breath-derived alcohol estimates peaked around the earlier assessment and declined thereafter. Whole-blood alprazolam concentrations increased between 30 and 100 minutes, when cognitive effects were generally most pronounced.
This timing limits what the absent additive effect means. The trial did not test every possible combination of dose and administration time, including conditions where peak exposures overlap more closely. It also did not demonstrate statistical equivalence or prove the absence of a smaller interaction.
It would therefore be unsound either to claim that this experiment proved synergy or to use it as proof that alcohol cannot add to alprazolam-related impairment.
Concentration reporting needs care
The alprazolam analytical method describes calibration in ng/mL, while the concentration table labels its values mg/L. Those units differ by a factor of 1,000. Without clarification, the table should not be quoted as a reliable numerical blood-concentration benchmark.
The study’s achieved breath-derived alcohol measurements also provide a firmer basis for describing exposure than silently assuming that a planned dose guaranteed its target. These reporting concerns do not erase the observed task comparisons, but they restrict concentration-specific conclusions.
Limits for a DUI assessment
The paper reports cognitive secondary outcomes from a larger research program. The results presented here are not direct driving results. Most tasks lasted only about 1.5–4 minutes, which may miss deficits that emerge during longer or more demanding activities.
Healthy volunteers without a clinical indication for alprazolam do not represent all treated patients or long-term users. The small sample, missing data exclusions and exploratory outlier handling also limit precision and generalization.
For a case opinion, the supported conclusion is that a therapeutic-sized alprazolam dose can impair selected functions even when the tested alcohol increment is not separately detectable. Exposure, time, observed behavior and alternative explanations still need individual evaluation. The site’s laboratory-versus-driving prediction analysis explains why a cognitive result does not automatically quantify driving ability.
Primary source
Aitken B and colleagues. Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study. Journal of Psychopharmacology. 2023;37:1227–1237. https://doi.org/10.1177/02698811231200878.